Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The Edison System for Treatment of Benign Prostatic Hyperplasia (BPH) Using Histotripsy

NCT: NCT07214675 · RECRUITING

NCT IDNCT07214675
StatusRECRUITING
Start Date2026-03-20
Completion2027-10

Brief Summary

The purpose of this trial is to evaluate the safety of histotripsy using the HistoSonics Edison System for treatment of BPH.

Frequently Asked Questions

What is The Edison System for Treatment of Benign Prostatic Hyperplasia (BPH) Using Histotripsy?

The Edison System for Treatment of Benign Prostatic Hyperplasia (BPH) Using Histotripsy is a clinical trial registered under NCT07214675. Current status: RECRUITING.

What is the status of NCT07214675?

The current status of NCT07214675 (The Edison System for Treatment of Benign Prostatic Hyperplasia (BPH) Using Histotripsy) is: RECRUITING.

When did The Edison System for Treatment of Benign Prostatic Hyperplasia (BPH) Using Histotripsy start?

The Edison System for Treatment of Benign Prostatic Hyperplasia (BPH) Using Histotripsy started on 2026-03-20.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑